Determinants and impact of suboptimal asthma control in Europe: The International Cross-Sectional and Longitudinal Assessment on Asthma Control (Liaison) study
EntidadUAM. Departamento de Medicina; Instituto de Investigación del Hospital de La Princesa (IP)
Fecha de edición2016-05-14
10.1186/s12931-016-0374-zRespiratory Research 17.1 (2016): 51
ISSN1465-9921 (print); 1465-993X (online)
Versión del editorhttp://dx.doi.org/10.1186/s12931-016-0374-z
MateriasAsthma control; Quality of Life; Liaison; Suboptimal control; Medicina
Derechos© 2016 Braido et al
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.
Background: According to the Global Initiative of Asthma, the aim of asthma treatment is to gain and maintain control. In the INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study, we evaluated the level of asthma control and quality of life (QoL), as well as their determinants and impact in a population consulting specialist settings. Methods: LIAISON is a prospective, multicentre, observational study with a cross-sectional and a 12-month longitudinal phase. Adults with an asthma diagnosis since at least 6 months, receiving the same asthma treatment in the 4 weeks before enrolment were included. Asthma control was assessed with the 6-item Asthma Control Questionnaire (ACQ) and QoL with the MiniAsthma Quality of Life Questionnaire (MiniAQLQ). Results: Overall, 8111 asthmatic patients were enrolled in 12 European countries. Asthma control was suboptimal in 56.5 % of patients and it was associated with poorer asthma-related QoL, higher risk of exacerbations and greater consumption of healthcare resources. Variables associated with suboptimal control were age, gender, obesity, smoking and comorbidities. Major determinants of poor asthma control were seasonal worsening and persisting exposure to allergens/irritants/triggers, followed by treatment-related issues. Conclusions: The cross-sectional phase results confirm that suboptimal control is frequent and has a high individual and economic impact. Trial registration: The clinicaltrials.gov identifier is NCT01567280.
Google Scholar:Braido, Fulvio - Brusselle, Guy - Guastalla, Daniele - Ingrassia, Eleonora - Nicolini, Gabriele - Price, David - Roche, Nicolás - Soriano, Joan B. - Worth, Heinrich - LIAISON Study Group
Lista de colecciones del ítem
Mostrando ítems relacionados por título, autor, creador y materia.
Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination Jiménez-Garrido, Daniel F.; Gómez-Sousa, María; Ona, Genís; Dos Santos, Rafael G.; Hallak, Jaime E.C.; Alcázar-Córcoles, Miguel Ángel; Bouso, José Carlos
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
Changes in sitting time, screen exposure and physical activity during covid-19 lockdown in south american adults: A cross-sectional study Sadarangani, Kabir P.; De Roia, Gabriela F.; Lobo, Pablo; Chavez, Robinson; Meyer, Jacob; Cristi-Montero, Carlos; Martinez-Gomez, David; Ferrari, Gerson; Schuch, Felipe B.; Gil-Salmerón, Alejandro; Solmi, Marco; Veronese, Nicola; Alzahrani, Hosam; Grabovac, Igor; Caperchione, Cristina M.; Tully, Mark A.; Smith, Lee